Efficacy, safety, compliance of dermatology products must be improved. Transdermal route must be expanded. Agigma fills a major product gap in these markets.
Agigma manufactures dissolving skin patch systems for drug delivery. With proprietary technology we fill a major product gap in dermatology and transdermal delivery. Initially we optimize the patch system for topical delivery of botulinum toxin, capitalizing on predecessors in clinical trials. We will sell products to drug manufacturers and dermatologists. Next we demonstrate superior efficacy/tolerability of selected dermatology drugs.